Loading clinical trials...
Loading clinical trials...
Phase II Study of Pemetrexed and Pembrolizumab in Recurrent and/or Metastatic Salivary Gland Malignancies
Conditions
Interventions
Pembrolizumab
Pemetrexed Disodium
+5 more
Locations
2
United States
Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
July 23, 2021
Primary Completion Date
August 13, 2025
Completion Date
February 28, 2028
Last Updated
February 2, 2026
NCT04704661
NCT05669664
NCT03146650
NCT03749460
NCT01175980
NCT01254617
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions